Prognostic value of minimal residual disease (MRD) in acute myeloid leukemia (AML) with favorable cytogenetics [t(8;21) and inv(16)]

G. Perea, A. Lasa, A. Aventín, A. Domingo, N. Villamor, M. Paz Queipo de Llano, A. Llorente, J. Juncà, C. Palacios, C. Fernández, M. Gallart, L. Font, M. Tormo, L. Florensa, J. Bargay, J. M. Martí, P. Vivancos, P. Torres, J. J. Berlanga, I. BadellS. Brunet, J. Sierra, J. F. Nomdedéu

Research output: Contribution to journalArticleResearchpeer-review

124 Citations (Scopus)

Fingerprint

Dive into the research topics of 'Prognostic value of minimal residual disease (MRD) in acute myeloid leukemia (AML) with favorable cytogenetics [t(8;21) and inv(16)]'. Together they form a unique fingerprint.

Medicine & Life Sciences